Renovaro BiosciencesRENB 
$1.03-8.04%24h
-8.04%24h
Global rank21627
Market cap$69.24M
Change 7d-41.14%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Renovaro Biosciences (RENB)
As of January 2025, Renovaro Biosciences has a market cap of $69.24M. This makes Renovaro Biosciences the world's 21627th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Renovaro Biosciences from 2018 to 2024
-
Value:-
Market cap history of Renovaro Biosciences from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $136.46M | -35.96% |
| 2023 | $213.10M | 207.77% |
| 2022 | $69.24M | -85.87% |
| 2021 | $490.06M | 147.12% |
| 2020 | $198.31M | -41.24% |
| 2019 | $337.46M | -28.29% |
| 2018 | $470.57M | - |
RENB Market Cap Today is $69.24M -8.04% - 22 Jan 2025
View largest stocks by market cap 
